BVF PARTNERS L P/IL Insider Trading $ALPN ALPINE IMMUNE SCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Over the past year BVF PARTNERS L P/IL has been an insider in 11 companies. The total value of shares held by BVF PARTNERS L P/IL in these companies amounts to $226,487,611.

BVF PARTNERS L P/IL 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
ARQULE INC
10% Owner
Calithera Biosciences, Inc.
Capstone Therapeutics Corp.
ChemoCentryx, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
Director, 10% Owner
CTI BIOPHARMA CORP
CYTOKINETICS INC
Eledon Pharmaceuticals, Inc.
FIVE PRIME THERAPEUTICS, INC.
10% Owner
GLYCOMIMETICS INC
IDEAYA Biosciences, Inc.
10% Owner
IMMUNE DESIGN CORP.
10% Owner
INFINITY PHARMACEUTICALS, INC.
Director
Kymera Therapeutics, Inc.
10% Owner
Merus N.V.
Director
Olema Pharmaceuticals, Inc.
10% Owner
PIERIS PHARMACEUTICALS, INC.
10% Owner
Principia Biopharma Inc.
Director
Rain Therapeutics Inc.
10% Owner
Syndax Pharmaceuticals Inc
10% Owner
Xenon Pharmaceuticals Inc.
Director, 10% Owner
XOMA Corp
$ 226487611 The total value of shares held by BVF PARTNERS L P/IL
Insider Rank

BVF PARTNERS L P/IL ranks 209 out of 350,000 insiders. Go to Insider Ranking to see more.

BVF PARTNERS L P/IL in ALPINE IMMUNE SCIENCES, INC.

Trading Symbol: ALPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,109,258 shares
Current Value: $2,595,664
Latest Transaction: Jun 22 2017
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 33x
Sell: 0x
Shares Bought: 325,348
Shares Sold: 0
Share Difference: +325,348
Value Difference: -$747,410

Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ALPINE IMMUNE SCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.251,7153,859201,811200.1 K to 201.8 K (+0.86 %)
Jun 22 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.256,35914,308717,089710.7 K to 717.1 K (+0.89 %)
Jun 22 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.259,73221,8971,109,2581.1 M to 1.1 M (+0.89 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.283,6738,379200,096196.4 K to 200.1 K (+1.87 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2813,04629,762710,730697.7 K to 710.7 K (+1.87 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2820,18146,0391,099,5261.1 M to 1.1 M (+1.87 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.293,9208,979196,423192.5 K to 196.4 K (+2.04 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2912,62428,917697,684685.1 K to 697.7 K (+1.84 %)
Jun 07 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2919,20643,9931,079,3451.1 M to 1.1 M (+1.81 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.252,7276,128192,503189.8 K to 192.5 K (+1.44 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2510,02322,522685,060675 K to 685.1 K (+1.48 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2515,35034,4911,060,1391 M to 1.1 M (+1.47 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.301,8054,144189,776188 K to 189.8 K (+0.96 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.306,90315,847675,037668.1 K to 675 K (+1.03 %)
Jun 01 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3010,19223,3981,044,7891 M to 1 M (+0.99 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.301,1242,585187,971186.8 K to 188 K (+0.60 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.304,2239,713668,134663.9 K to 668.1 K (+0.64 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.306,25314,3821,034,5971 M to 1 M (+0.61 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.302,9096,690186,847183.9 K to 186.8 K (+1.58 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3010,54124,242663,911653.4 K to 663.9 K (+1.61 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3016,43637,8001,028,3441 M to 1 M (+1.62 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.305,51012,666183,938178.4 K to 183.9 K (+3.09 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.306,89715,854653,370646.5 K to 653.4 K (+1.07 %)
May 19 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3024,96557,3871,011,908986.9 K to 1 M (+2.53 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.346751,581178,428177.8 K to 178.4 K (+0.38 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.342,5656,010646,473643.9 K to 646.5 K (+0.40 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.343,7948,889986,943983.1 K to 986.9 K (+0.39 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.356,21714,583177,753171.5 K to 177.8 K (+3.62 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3522,09251,821643,908621.8 K to 643.9 K (+3.55 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.3533,69179,029983,149949.5 K to 983.1 K (+3.55 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.293,9298,989171,536167.6 K to 171.5 K (+2.34 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2914,27432,657621,816607.5 K to 621.8 K (+2.35 %)
May 11 2017NVLSNivalis Therapeuti ...BVF PARTNERS L P/IL10% OwnerBuyP2.2921,79749,869949,458927.7 K to 949.5 K (+2.35 %)

Page:   1